Financials

  • Market Capitalization 1.84 B
  • Employee 99
  • Founded 2019
  • CEO N/A
  • Website www.tayshagtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00TJXFDP1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-16.21
市销率
396.94

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2045
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
20.78 USD+3.38%+3.85%+6.24%+27.72%1.86 B USD
2050
INBX
Inhibrx Biosciences, Inc. - Common Stock
124.97 USD+0.25%+0.56%+47.30%+55.09%1.84 B USD
2060
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.38 USD+1.50%-3.70%+4.00%-26.52%1.81 B USD
2071
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.76 USD+0.55%-3.77%+17.28%-7.00%1.79 B USD

新闻